Pulmonary therapy
Home-Based FeNO Monitoring with the Vivatmo me Device Reveals Type 2 Inflammatory Patterns of Patients with Asthma at Different Treatment Steps: The FeNO@Home Study.
Kai M Beeh, Tim Harrison, Enrico Heffler, Hartmut Timmermann, Stephan Weber, Sandra Wegner
Published: 202510.1007/s41030-025-00336-9
Abstract
INTRODUCTION: Fractional exhaled nitric oxide (FeNO) is an important type 2 (T2) asthma biomarker. Home-based FeNO monitoring can provide longitudinal data better reflecting the variable nature of T2 inflammation versus single-point data. We sought t…
Preview only. Read the full abstract at the source